Executive Summary
Across 40 filings in the USA Executive & Director Changes stream (March 31, 2026), a dominant theme is leadership consolidation and transitions, with BlackRock appointing Jay Jacobs as President/CEO across 7 iShares ETF sponsors (Bitcoin, Silver, Gold Micro/IAU, Ethereum, Staked Ethereum, Commodity-Indexed Trusts), replacing Shannon Ghia without disputes, signaling centralized expertise amid crypto/commodity volatility. Positive appointments dominate (e.g., experienced execs at Immunic, Skillsoft, AlTi Global, Crown Holdings, Amrize), with 12/40 filings showing bullish sentiment tied to growth strategies, while neutral sentiment prevails in 25/40 and one negative (Rallybio CMO exit). Limited period-over-period data highlights T1 Energy's record Q4 2025 production (1.13 GW, +YoY sales $358.5M) and improved net loss (-$190M vs -$367M Q4 2024), maintaining 2026 guidance (3.1-4.2 GW); other trends include AlTi's $93B AUM and Amrize's $11.8B 2025 revenue. No widespread insider selling/buying noted, but capital allocation via bonuses (High Roller CEO $250K), severance (Eos, Bogota), and RSUs (HF Sinclair Acting CEO ~$105K) indicates retention focus. Portfolio implications: Stability in finance/biotech (e.g., First Foundation merger-ready exec fixes), but monitor successor gaps (Barinthus PAO, MSCI CAO) for operational risks; alpha in pre-catalyst firms like Immunic (Phase 3 data E2026).
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from March 25, 2026.
Investment Signals(12)
- T1 Energy Inc.↓(BULLISH)▲
Record Q4 2025 module production 1.13 GW and net sales $358.5M (full-year 2.79 GW in-line guidance), net loss improved YoY to -$190M (vs -$367M Q4 2024), 2026 guidance maintained 3.1-4.2 GW with $160M PTC sale
- First Foundation Inc.↓(BULLISH)▲
Amended President/CRO and new CFO agreements ensure continuity pre-merger closure April 1, 2026 (all approvals secured), no disruptions noted
- AlTi Global, Inc.↓(BULLISH)▲
Nancy Curtin (ex-GCIO) appointed Interim CEO managing $93B AUM, prior CEO advisory role supports seamless transition
- Immunic, Inc.↓(BULLISH)▲
Jon Congleton (40yrs biopharma, Copaxone launch) joins board ahead of IMU-838 Phase 3 top-line data end-2026
- SmartFinancial Inc.↓(BULLISH)▲
Cynthia Cain promoted COO overseeing AI/Data/Innovation, 30+ yrs exp amid rapid banking changes
- Crown Holdings, Inc.↓(BULLISH)▲
Dr. John Rost promoted EVP/COO Asia Pacific/Transit Packaging (from regional President), drove volume growth/sustainability
- Amrize Ltd↓(BULLISH)▲
Baris Oran (25yrs finance) new CFO post $11.8B 2025 revenue, succeeding 27-yr veteran to advisor
- Skillsoft Corp.↓(BULLISH)▲
Art Gilliland (CEO Delinea, Symantec/Broadcom) board add for AI/cyber growth, serves 105M learners/60% Fortune 1000
- Ponce Financial Group↓(BULLISH)▲
Marlene Cintron (Citibank/Merrill/SBA) board appointment strengthens community finance/MDI focus
- Toll Brothers, Inc.↓(BULLISH)▲
Planned CEO succession (Karl Mistry from Douglas Yearley to Exec Chairman), board expanded to 10
$250K CEO/$50K CFO bonuses signal compensation alignment post-Q4 [POSITIVE, BULLISH]
- iShares Trusts (7 filings)(BULLISH)▲
Jay Jacobs (BlackRock MD, ETF expert) unified leadership across BTC/ETH/Gold/Silver/Commodity trusts
Risk Flags(9)
- Rallybio Corp./CMO Departure↓[HIGH RISK]▼
Chief Medical Officer Steven Ryder exits March 31, 2026 amid Candid Therapeutics merger (March 1 agreement), severance tied to close
- Barinthus Biotherapeutics/PAO Resignation↓[MEDIUM RISK]▼
Gemma Jones steps down April 30, 2026, no successor named
- MSCI Inc./CAO Resignation↓[MEDIUM RISK]▼
C. Jack Read resigns August 9, 2026 to join State Street, search initiated
- Shimmick Corp./CEO Retirement↓[MEDIUM RISK]▼
Steven Richards retires end-2026 post-IPO guidance, board shrinks to 5
- Bogota Financial/CLO Retirement↓[MEDIUM RISK]▼
Robert Walsh retires March 31, 2026, no successor, consulting thru July
- Selectis Health/Director Resignation↓[MEDIUM RISK]▼
David Furstenberg resigns March 30, 2026 immediately
- HF Sinclair/Acting CEO↓[MEDIUM RISK]▼
Franklin Myers (73) interim comp via RSUs/stipend, quarterly review amid leadership gap
- CaliberCos Inc./Director Changes↓[LOW-MEDIUM RISK]▼
Dan Hansen/Michael Trzupek not re-elect May 14, 2026 annual meeting
- T1 Energy Inc./Ongoing Losses↓[MIXED RISK]▼
Q4 net loss $190M (improv YoY but FY -$380.8M), $350M capex remaining for G2
Opportunities(8)
BlackRock ETF expert centralizes 7 trusts' sponsorship, potential AUM growth in crypto/commodities
- Immunic, Inc./Phase 3 Catalyst↓(OPPORTUNITY)◆
Board bolstered by Congleton pre-end-2026 IMU-838 MS trial data
- First Foundation Inc./Merger Close↓(OPPORTUNITY)◆
Exec continuity (CFO $390K salary/severance) ahead April 1, 2026 FirstSun merger
- T1 Energy/Growth Ramp↓(OPPORTUNITY)◆
Maintained 2026 3.1-4.2 GW guidance, 2027 EBITDA $375-450M run-rate post-G2 Q4 2026
- AlTi Global/Interim Stability↓(OPPORTUNITY)◆
$93B AUM firm with Curtin (ex-GCIO) interim CEO, advisory from prior CEO
- Amrize Ltd/CFO Transition↓(OPPORTUNITY)◆
New CFO Oran post-$11.8B 2025 rev, logistics scale potential
- Crown Holdings/Promotion↓(OPPORTUNITY)◆
Rost's Asia/Transit ops oversight post-volume growth, Twentyby30 sustainability
- SmartFinancial/Tech Focus↓(OPPORTUNITY)◆
New COO Cain on AI/Governance amid banking innovation
Sector Themes(6)
- ETF Leadership Centralization◆
7/40 filings (iShares BTC/ETH/Gold/Silver/Commodity) show Jay Jacobs replacing Ghia across BlackRock sponsors (neutral sentiment), implies streamlined crypto/commodity mgmt amid volatility [IMPLICATION: Bullish AUM efficiency]
- Finance/Banking Exec Promotions◆
6 firms (First Foundation, SmartFinancial, Ponce, State Street, Bogota, Amrize) with CFO/COO/CLO changes, positive/neutral sentiment, comp via salary/bonuses/severance; e.g., Amrize $11.8B rev [IMPLICATION: Stability pre-mergers/digital shift]
- Biotech/Health Board Adds & Exits◆
5 filings (Immunic positive board add, Rallybio CMO exit negative, Barinthus PAO resign, Selectis dir resign, eHealth dir not re-elect), Phase 3 catalysts noted [IMPLICATION: Monitor trials/mergers for volatility]
- Planned Retirements/Successions◆
8/40 (Shimmick CEO, SiteOne SVP, HF Sinclair acting, CaliberCos dirs), mostly neutral w/consulting/severance, no disputes [IMPLICATION: Low disruption if successors named]
- Positive Comp/Bonus Signals◆
Bonuses/RSUs in High Roller ($250K CEO), Eos (75% bonus target), HF Sinclair ($105K RSUs), amid neutral/positive sentiment [IMPLICATION: Retention focus supports near-term execution]
- M&A/Interim Leadership◆
3 filings (First Foundation merger April 1, Rallybio merger, AlTi interim CEO), exec fixes pre-close [IMPLICATION: Arbitrage potential on continuity]
Watch List(8)
$350M capex remaining, on-schedule Q4 2026 start, 2027 EBITDA $650-700M full ramp [Q4 2026]
IMU-838 relapsing MS top-line results [End-2026]
All approvals, exec continuity for FirstSun deal [April 1, 2026]
Gemma Jones exit, no replacement named [April 30, 2026]
C. Jack Read departure to State Street [August 9, 2026]
New dir Reid nomination, Hansen/Trzupek not re-elect [May 14, 2026]
Renee Budig Class III re-election post-rebalance [June 12, 2026]
Andrea Brimmer steps down [June 18, 2026]
Filing Analyses(40)
31-03-2026
T1 Energy reported record Q4 2025 module production of 1.13 GW at G1_Dallas, generating record net sales of $358.5 million, with full-year production of 2.79 GW in line with guidance. However, the company recorded a Q4 net loss attributable to common stockholders of $190.0 million (improved from $367.2 million in Q4 2024) and full-year net loss of $380.8 million (versus $450.2 million in 2024). Construction on the 2.1 GW Phase 1 of G2_Austin is on schedule for Q4 2026 production start, with remaining capital spending of approximately $350 million.
- ·2026 production and sales guidance maintained at 3.1 – 4.2 GW with 3 GW contracted.
- ·Annualized run-rate Adjusted EBITDA guidance: $375 - $450 million in 2027 upon G2 Phase 1 completion; $650 - $700 million at full 5 GW integrated G1/G2 production.
- ·First sale of Section 45X PTCs for $160 million at $0.91 per dollar to a U.S. financial institution.
- ·Three-year contract with Treaty Oak for minimum 900 MW of solar modules.
- ·Construction start on G2_Austin Phase 1 in December 2025, anticipated $400 - $425 million total capex.
31-03-2026
On March 25, 2026, the Board of Directors of High Roller Technologies, Inc. (ROLR), upon recommendation of the Compensation Committee, approved discretionary cash bonuses of $250,000 to CEO Seth Young and $50,000 to CFO Adam Felman. This action falls under Item 5.02 of the 8-K filing related to compensatory arrangements for certain officers. No officer departures, elections, or other changes were reported.
31-03-2026
EOS Energy Enterprises, Inc. entered into a new employment agreement with its Chief Administration Officer, Michelle Buczkowski, on March 30, 2026, superseding her prior offer letter. The agreement sets an annual base salary of $385,000, eligibility for a target year-end bonus of 75% of base salary, and annual long-term incentive grants. It also includes severance provisions for involuntary termination, such as 12 months of continued base salary and accelerated vesting of certain equity awards.
- ·Severance includes prorated annual bonus if three full months of service completed in applicable year.
- ·Non-competition and non-solicitation restrictions apply for 12 months post-termination.
- ·Customary confidentiality and intellectual property assignment obligations are perpetual.
31-03-2026
Ponce Financial Group, Inc. appointed Marlene Cintron, a current member of Ponce Bank, NA's Board of Directors, to its own Board effective March 26, 2026. Cintron brings over three decades of experience in economic development, public policy, finance, and community advocacy, including leadership roles at Citibank, Merrill Lynch, BOEDC, and as SBA Region 2 Administrator where she oversaw a 20% increase in small business growth. The appointment is expected to strengthen leadership focused on community investment and growth.
- ·Marlene Cintron holds a law degree from Georgetown University and a master’s degree in education administration from Fordham University.
- ·Cintron served as a mayoral appointee to the NYCEDC board and gubernatorial appointee to the Regional Economic Development Council.
- ·Ponce Bank, N.A. is a Minority Depository Institution, Community Development Financial Institution, and certified SBA lender.
31-03-2026
On March 20, 2026, Steven Richards notified the Shimmick Corporation Board of his retirement, effective at the end of his term at the 2026 annual meeting of stockholders. Mr. Richards, who served as CEO from March 2020 through December 2024 and guided the company's November 2023 IPO, has been with the company for 45 years. In connection with his retirement, the Board expects to reduce its size to five members.
- ·Company is an emerging growth company
- ·Common Stock trades on NASDAQ under SHIM with $0.01 par value
31-03-2026
Goosehead Insurance, Inc. announced the appointment of Martin Thornthwaite as General Counsel and Corporate Secretary, effective March 30, 2026, bringing experience from RealPage, Inc., Clark Hill PLC, and Strasburger & Price LLP. Simultaneously, John O’Connor is departing the company to pursue other opportunities. The leadership change occurs as Goosehead continues to grow as an independent personal lines insurance agency representing over 200 insurance companies.
- ·Filing date: March 31, 2026
- ·Appointment effective date: March 30, 2026
- ·Investor contact: Phone (972) 800-1993, Email: madeline.middleton@goosehead.com or IR@goosehead.com
31-03-2026
First Foundation Inc. amended Simone Lagomarsino's employment agreement as President and Chief Risk Officer, extending the term to December 31, 2027, and entered a new employment agreement with James Britton as EVP and CFO, including a $390,000 annual base salary and severance provisions. The company also announced receipt of Federal Reserve approval for its merger with FirstSun Capital Bancorp, with all stockholder and regulatory approvals now obtained and closure expected on April 1, 2026. These actions ensure executive continuity ahead of the merger with no reported disruptions.
- ·Lagomarsino Amendment: No other material changes to original February 11, 2025 agreement.
- ·Britton severance: Lump sum equal to lesser of 12 months base salary or remaining term if terminated without cause or for good reason.
- ·Britton death benefit: 100% of base annual salary to beneficiaries.
- ·Britton: No severance if terminated for cause or upon term expiration (December 31, 2027).
31-03-2026
Skillsoft (NYSE: SKIL) appointed Art Gilliland, CEO of Delinea, to its Board of Directors effective March 25, 2026, bringing over 25 years of experience in cybersecurity, enterprise software, and AI leadership from roles at Symantec, Broadcom, Skyport Systems, HP, and others. CEO Ron Hovsepian highlighted Gilliland's expertise in scaling businesses and AI as key to Skillsoft's growth in AI-native skills management. The company supports a global community of more than 105 million learners and is trusted by 60% of the Fortune 1000.
- ·Art Gilliland holds a bachelor’s degree in Economics from Carleton College and a Master’s of Business Administration from Harvard Business School.
- ·Gilliland serves on the boards of OneSpan (OSPN) and Gigamon, and is a member of Forbes Technology Council and The Wall Street Journal Leadership Institute.
- ·Investor contact: Ross Collins at SKIL@alpha-ir.com; Media contact: Vito Gallo at vito.gallo@skillsoft.com.
31-03-2026
Immunic, Inc. (Nasdaq: IMUX) appointed Jon Congleton, a biopharmaceutical executive with nearly 40 years of experience including key roles in the U.S. launch of Copaxone® for multiple sclerosis and current CEO of Mineralys Therapeutics, Inc., to its Board of Directors effective March 27, 2026. This move aims to strengthen leadership expertise in CNS and commercialization as the company advances vidofludimus calcium (IMU-838) through phase 3 trials for relapsing multiple sclerosis, with top-line data expected by end of 2026. No financial impacts or performance metrics were disclosed.
- ·Appointment effective March 27, 2026
- ·Top-line data for IMU-838 phase 3 trials in relapsing MS expected by end of 2026
- ·Jon Congleton's experience: nearly 40 years in biopharmaceuticals, including U.S. neuroscience business at Teva
31-03-2026
AlTi Global, Inc. (NASDAQ: ALTI) announced the appointment of Nancy Curtin as Interim Chief Executive Officer and to its Board of Directors, effective immediately, succeeding Michael Tiedemann who will remain available in an advisory capacity. The company, a leading global wealth manager, currently manages or advises on over $93 billion in assets with more than 450 professionals globally. Ms. Curtin, previously Global Chief Investment Officer, has led a team of more than 50 investment professionals and brings extensive experience from prior roles at Alvarium Investments and other firms.
- ·Filing date: March 31, 2026
- ·Ms. Curtin serves as Chairperson of the Board of Directors of Digital Bridge Group Inc.
31-03-2026
SmartBank promoted Cynthia A. Cain to Chief Operating Officer, effective March 31, 2026, to oversee Operations, Technology, Data, AI Governance, Digital & Innovation, and Payments functions, strengthening leadership amid rapid industry changes. Ms. Cain brings more than 30 years of experience, including prior roles as Chief Accounting Officer at SmartBank since 2019 and Senior Vice President at South State Bank. The appointment positions the bank for long-term growth and operational excellence.
- ·SmartBank founded in 2007.
- ·Loan production offices in Columbus, Georgia, and Brentwood, Tennessee.
- ·Media contact: kelley.fowler@smartbank.com
31-03-2026
On March 27, 2026, the Board of Directors of Yunhong Green CTI Ltd. (YHGJ) appointed Fred H.F. Chak as a Director, as disclosed in this Form 8-K filing under Items 5.02 and 8.01. The filing was signed by Jana M. Schwan, Chief Executive Officer, on March 31, 2026. No financial impacts, departures, or other material events were reported.
- ·Securities registered: Common Stock (YHGJ) on The Nasdaq Capital Market
- ·Registrant details: Incorporated in Illinois, Commission File Number 000-23115, IRS Employer Identification No. 36-2848943, Address: 22160 N. Pepper Road, Lake Barrington, IL 60010
31-03-2026
Barinthus Biotherapeutics plc announced that Gemma Jones, its principal accounting officer who provides services as an employee of CFGI, notified the company on March 27, 2026, that she will step down effective April 30, 2026. No successor has been named in the filing. The announcement is part of Item 5.02 of Form 8-K filed on March 31, 2026.
31-03-2026
Toll Brothers, Inc. increased its Board size from 9 to 10 members and appointed Karl K. Mistry as a Director effective March 30, 2026, with his term expiring at the 2027 annual meeting. As part of its previously announced CEO succession plan, Mistry succeeded Douglas C. Yearley, Jr. as Chief Executive Officer, while Yearley assumed the role of Executive Chairman. No other changes, such as committee assignments or material transactions, were disclosed.
- ·Mr. Mistry is not expected to be appointed to any Board committee.
- ·No arrangements or understandings between Mr. Mistry and any other person for his selection as director.
- ·Mr. Mistry has no direct or indirect material interest in any transaction required to be disclosed under Item 404(a) of Regulation S-K.
31-03-2026
Advantage Solutions Inc. disclosed that Dean General, who transitioned to Chief Industry Development Officer on August 8, 2025, ceased serving as an executive officer effective March 26, 2026, per definitions under Rules 3b-7 and 16a-1(f) of the Securities Exchange Act. The filing, dated March 31, 2026, contains no financial impacts, compensatory details, or performance metrics related to this change.
- ·Previous disclosure of Dean General's role transition in Form 8-K filed August 8, 2025.
- ·No exhibits beyond Inline XBRL cover page (Exhibit 104).
31-03-2026
On March 25, 2026, Chegg, Inc. rebalanced its Board of Directors by moving Renee Budig from Class I to Class III through a resignation and immediate re-election to achieve more equal class composition. The Board now consists of two Class I directors, one Class II director, and two Class III directors, with her service deemed uninterrupted. Ms. Budig will stand for election as a Class III director at the 2026 Annual Meeting on June 12, 2026, for a term ending at the 2028 Annual Meeting.
- ·Filing signed by David Longo on March 31, 2026.
- ·Rebalance effected solely for board class composition; no other changes to Ms. Budig's service.
31-03-2026
On March 30, 2026, David Furstenberg resigned as a member of the Board of Directors and Audit Committee of Selectis Health, Inc., effective immediately. The company thanked him for his service and support. No successor or additional details on the resignation were provided.
- ·Filing dated March 31, 2026, reporting event of March 30, 2026
- ·Registrant is an emerging growth company
31-03-2026
Effective March 25, 2026, Jeff Woolard, Chief Financial Officer of Cirrus Logic, Inc., assumed the additional role of Principal Accounting Officer. Ulf Habermann ceased serving as Principal Accounting Officer but will continue in a senior role within the Company's finance organization. The transition was not due to any disagreement, and Woolard's compensation remains unchanged.
- ·Information regarding Mr. Woolard’s background, business experience, compensation arrangements, and related party transactions is incorporated by reference from the Company’s proxy statement on Schedule 14A filed June 4, 2025.
- ·The Form 8-K was signed by Jeff Woolard on March 31, 2026.
31-03-2026
Crown Holdings, Inc. (NYSE: CCK) appointed Dr. John M. Rost as Executive Vice President and Chief Operating Officer – Asia Pacific and Transit Packaging, effective April 1, 2026. Previously President of the Asia Pacific region based in Singapore, Dr. Rost will now oversee Asia Pacific and global Transit Packaging operations from Tampa, FL, reporting to Timothy J. Donahue, Chairman, President and CEO. The promotion recognizes his enhancements to partner relationships, volume growth in Asia-Pacific, and leadership in technology, sustainability, and the Twentyby30 program.
- ·Announcement date: March 26, 2026
- ·Dr. Rost joined Crown in 1997; previously Senior Vice President – Technology, Sustainability and Regulatory Affairs
- ·Dr. Rost holds a Bachelor of Science in Chemistry from Northern State University and a Ph.D. in Organic Chemistry from Loyola University Chicago
- ·Investor contact: Thomas T. Fischer, (215) 552-3720
31-03-2026
On March 27, 2026, C. Jack Read informed MSCI Inc. of his intention to resign as Global Controller and Chief Accounting Officer to pursue another opportunity, with his service continuing until August 9, 2026. His departure was not due to any disagreement with the company regarding financial statements, internal controls, operations, policies, or practices. MSCI has initiated a search for a successor.
- ·Filing date: March 31, 2026
- ·Event reported date: March 27, 2026
- ·Mr. Read will remain principal accounting officer until August 9, 2026
31-03-2026
State Street Corporation appointed C. Jack Read as Executive Vice President, Global Controller and Chief Accounting Officer, effective August 10, 2026, succeeding Elizabeth M. Schaefer. The appointment was made on March 27, 2026, via a letter agreement providing Mr. Read an annualized base salary of $450,000, target 2026 incentive compensation of $2,100,000, and one-time transition payments of $1,730,000 in deferred stock and $700,000 in cash. No financial performance metrics or period-over-period comparisons were disclosed.
- ·C. Jack Read, age 57, served as Managing Director, Global Controller and Chief Accounting Officer at MSCI Inc. since August 2024, and previously as Executive Vice President, Controller and Chief Accounting Officer at Citizens Financial Group from August 2018 to August 2024.
- ·Prior to Citizens, Mr. Read held senior roles at MUFG Americas, JPMorgan Chase, Washington Mutual Bank, and was a tax advisory partner at KPMG.
- ·Filing signed by Mark Shelton on March 31, 2026.
31-03-2026
Amrize Ltd (NYSE: AMRZ) appointed Baris Oran as Chief Financial Officer and Executive Committee member effective April 1, 2026, succeeding Ian Johnston, who will transition to a senior advisor role. Oran joins from GXO Logistics with 25 years of finance experience across industries. The company achieved $11.8 billion in revenue in 2025, employs 19,000 teammates, and operates over 1,000 sites across North America.
- ·Appointment announced March 31, 2026, effective April 1, 2026
- ·Ian Johnston served 27 years, key in spin-off from Holcim and public listing
- ·Oran holds MBA from University of Georgia
31-03-2026
eHealth, Inc. (Nasdaq: EHTH) announced that director Andrea Brimmer will not stand for re-election and will step down at the annual shareholders' meeting on June 18, 2026, after nearly eight years on the Board. CEO Derrick Duke commended her leadership and contributions to the company's strategy. Brimmer expressed pride in eHealth's progress and ongoing support for its mission as a leading online health insurance marketplace.
- ·Andrea Brimmer will continue serving until term expiration at June 18, 2026 annual meeting
- ·eHealth media inquiries: pr@ehealth.com
31-03-2026
Dr. Benjamin J. Allen, a member of the Board of Directors of Heartland Express, Inc., notified the company on March 25, 2026, of his decision not to stand for re-election at the 2026 Annual Meeting of Stockholders. He will continue serving on the Board as Chairperson of the Compensation Committee and a member of the Audit and Risk Committee until the Annual Meeting, with the decision not resulting from any disagreements with management or the Board. The company expressed thanks for his 31 years of dedicated service.
- ·Date of earliest event reported: March 25, 2026
- ·Filing date: March 31, 2026
- ·Registrant state of incorporation: Nevada
- ·IRS Employer Identification No.: 93-0926999
31-03-2026
Cynthia Collins, a member of Certara, Inc.'s Board of Directors and Audit Committee, notified the company on March 27, 2026, of her intention to resign as a Class II director effective May 14, 2026, the date of the 2026 annual meeting of stockholders. Ms. Collins stated that her resignation is not the result of any disagreement with the company's operations, policies, or practices. The filing was signed by Daniel D. Corcoran, Senior Vice President and General Counsel.
31-03-2026
HF Sinclair Corporation detailed compensation arrangements for its Acting CEO and President, Franklin Myers (age 73), appointed temporarily effective February 17, 2026, including a $9,000 monthly cash stipend for business expenses and restricted stock unit grants with approximately $105,000 grant date value (one-time initial grant and monthly follow-on grants starting April 2026). These arrangements were recommended by the Compensation Committee and approved by the Board of Directors, with Mr. Myers forgoing separate compensation for his Board service during this period. The Board will review these arrangements at least quarterly.
- ·RSU Grants governed by HF Sinclair Corporation Amended and Restated 2020 Long Term Incentive Plan.
- ·Previous announcement of appointment in Form 8-K filed February 18, 2026.
- ·Date of earliest event reported: March 25, 2026; Filing date: March 31, 2026.
31-03-2026
Sow Good Inc. designated 1,500,000 shares of Series AAA Convertible Redeemable Preferred Stock (par value $0.001 per share) via a board resolution adopted on February 13, 2026, as filed in an 8-K on March 31, 2026. The series has a stated value of $2.00 per share, conversion price of $0.008 (subject to stockholder approvals for charter amendment and Nasdaq compliance), and redemption price of $200.00 per share, ranking senior to common stock in liquidation. Holders have limited voting rights and are entitled to participating dividends equivalent to common stock conversion.
- ·Preferred stock ranks senior to Common Stock and junior securities in liquidation, pari passu with parity securities.
- ·Conversion requires stockholder approval for increased authorized Common Stock and Charter Amendment.
- ·Holders cannot vote on common matters until Series AA Preferred Stock is convertible, except for protective provisions requiring Requisite Holders' approval.
31-03-2026
CaliberCos Inc. (Nasdaq: CWD) nominated J. Alan Reid, Jr. as an independent director with over 30 years in asset management, including scaling Forward Management AUM from $70M to $7B and expertise in digital assets and tokenization, to chair the Compensation Committee post-election. Directors Dan Hansen and Michael Trzupek will not stand for re-election at the May 14, 2026 annual meeting due to expanded roles at Hyatt and Xanadu respectively, with no disagreements noted and Hansen continuing in an advisory capacity. The board is expected to consist of five members, including three independents: Reid, Lawrence Taylor, and Bill Gerber.
- ·Caliber has a 17-year track record investing in middle-market hospitality and multifamily real estate.
- ·In 2025, Caliber integrated digital asset infrastructure by investing in LINK.
31-03-2026
Robert Walsh, Executive Vice President and Chief Lending Officer of Bogota Savings Bank (wholly-owned subsidiary of Bogota Financial Corp.), notified his intention to retire effective March 31, 2026, and entered into a Retirement and Consulting Agreement providing a $15,000 lump sum pro-rated incentive payment and immediate vesting of unvested stock options. Under the agreement, Walsh will provide consulting services at $10,000 per month through July 2026 in exchange for a release of claims and post-employment restrictions including one-year non-solicitation of employees and customers. No successor has been announced in the filing.
- ·Agreement includes immediate vesting of unvested stock options, exercisable during original 10-year term.
- ·Post-employment obligations: one-year non-solicitation of employees and customers, standard confidentiality provisions.
- ·Notification of retirement intention occurred on March 25, 2026.
31-03-2026
SiteOne Landscape Supply, Inc. announced the retirement of Scott Salmon as Executive Vice President of Strategy and Development, effective March 31, 2026, and the appointment of Daniel Laughlin, currently Senior Vice President of Strategy and Development, as his successor, who will also join the Executive Leadership Team on the same date. Salmon, who joined in 2019, led the addition of over 70 companies through acquisitions and improved integration processes. The company anticipates a seamless transition given Laughlin's prior experience at SiteOne from 2014-2021 and recent roles elsewhere.
- ·Scott Salmon joined SiteOne in 2019.
- ·Daniel Laughlin served in leadership roles at SiteOne from 2014 to 2021 and rejoined in January 2026.
- ·Daniel Laughlin holds a degree in Finance and Accounting from the University of North Carolina at Charlotte and an MBA from Wake Forest University School of Business.
- ·Following transition, Scott Salmon will remain in a limited capacity for a duration of time.
31-03-2026
Oglethorpe Power Corporation held its annual meeting on March 30, 2026, where members elected five directors by acclamation: Ernest A. “Chip” Jakins III for member group 5, Marshall S. Millwood for member group 3, Danny L. Nichols for member group 2, Horace H. Weathersby III as member at-large, and James I. White for member group 1. Each director was elected for a term expiring in March 2029. The filing references Item 10 of the FY 2025 Form 10-K for additional details on the board and election procedures.
- ·Election conducted by acclamation as per bylaws
- ·No securities registered pursuant to section 12(b) of the Act
31-03-2026
Electronic Servitor Publication Network, Inc. appointed Thomas Spruce as Chief Financial Officer effective May 14, 2024, resulting in him serving as Chief Operating Officer, Chief Financial Officer, Secretary, and Sole Director. Mr. Spruce, aged 69, has extensive experience including President and CEO of His Speed, Inc. since 2008 and prior management roles at Principle Pharmacy Group, MediqPRN/Hill-Rom, and Owen Healthcare/Cardinal Health. The filing was signed by Peter Hager, Chief Executive Officer.
- ·Thomas Spruce is age 69 and holds a Bachelor of Sciences in Pharmacy from the University of Arkansas.
- ·Fellow at the American College of Healthcare Executives.
- ·Event effective date: May 14, 2024; Filing date: March 31, 2026.
31-03-2026
Rallybio Corporation announced the immediate departure of its Chief Medical Officer, Steven Ryder, M.D., effective March 31, 2026, after serving since January 2019. Under the separation agreement, Dr. Ryder will receive initial severance payments for a termination without cause, plus additional change-of-control severance upon closing of the pending merger with Candid Therapeutics, Inc., per the March 1, 2026 Merger Agreement. His equity awards remain outstanding and eligible to vest according to merger terms, exercisable for 90 days post-closing.
- ·Separation Agreement to be filed with Q1 2026 Form 10-Q
- ·Merger Agreement dated March 1, 2026
Get daily alerts with 12 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 40 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)